New combo therapy tested to restore skin color in vitiligo

NCT ID NCT07152626

Not yet recruiting Disease control Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

Summary

This study is testing if a daily pill called ritlecitinib works better for vitiligo when combined with twice-weekly UV light treatments. It will involve 56 adults with non-segmental vitiligo and compare the two approaches over one year. The main goal is to see which method leads to more repigmentation, especially on the face and body.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VITILIGO are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHu de Nice, Hôpital Archet

Nice, Alpes-Maritime, 06200, France

Contact Email: •••••@•••••

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

VITILIGO